EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody

BACKGROUND: The availability of a reliable tumor target for advanced colorectal cancer (CRC) therapeutic approaches is critical since current treatments are limited. Epidermal growth factor-like domain 6 (EGFL6) has been reported to be associated with cancer development. Here, we focused on the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Ting-Yi, Huang, Han-Li, Cheng, Chun-Chun, Chang, Fu-Ling, Wei, Po-Li, Cheng, Ya-Wen, Huang, Cheng-Chiao, Lee, Yu-Ching, HuangFu, Wei-Chun, Pan, Shiow-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962215/
https://www.ncbi.nlm.nih.gov/pubmed/33726836
http://dx.doi.org/10.1186/s13578-021-00561-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962215/
https://www.ncbi.nlm.nih.gov/pubmed/33726836
http://dx.doi.org/10.1186/s13578-021-00561-0

Ejemplares similares